Carlos de Sousa
Chief Executive Officer presso ULTIMOVACS ASA
Patrimonio netto: 11 011 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Carlos de Sousa
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
13
| Public Company | Biotechnology | 13 |
University of Lisbon
11
| College/University | Other Consumer Services | 11 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Carlos de Sousa tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BANCO ESPÍRITO SANTO, S.A. | Regional Banks | Chairman Director/Board Member | |
| BANCO COMERCIAL PORTUGUÊS, S.A. | Major Banks | Director/Board Member Chairman Director/Board Member | |
Oslo Cancer Cluster NCE
 Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
| DIGNITANA AB | Medical Specialties | Director/Board Member Director/Board Member | |
Caixa Geral de Depósitos SA
 Caixa Geral de Depósitos SA Major BanksFinance Caixa Geral de Depósitos SA engages in the provision of commercial banking services. The company offers savings, checking, and deposit accounts, personal and business loans, mortgages, credit card issuing, corporate financing, life insurance, and pension funds. It offers financial advisory, online stock broking, and portfolio management. The company was founded on April 10, 1876 and is headquartered in Lisbon, Portugal. | Major Banks | Director/Board Member | |
| EDP - ENERGIAS DE PORTUGAL, S.A. | Electric Utilities | Francisco de la Fuente Sánchez | Chairman Director/Board Member Director/Board Member |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member Chief Executive Officer | |
| VITROLIFE AB | Medical Specialties | Chief Executive Officer | |
| AstraZeneca AS | Corporate Officer/Principal | ||
| ALLENEX AB | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree | |
Watrium AS
 Watrium AS Financial ConglomeratesFinance Watrium AS engages in active, long-term ownership of a global financial portfolio, industrial assets and top-tier commercial property. The company was founded in 2002 and is headquartered in Oslo, Norway. | Financial Conglomerates | Director/Board Member Chief Investment Officer | |
| University of Lund | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Oslo | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Leiden | College/University | Graduate Degree Graduate Degree | |
| University of Groningen | College/University | Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Norwegian School of Economics & Business Administration | College/University | Masters Business Admin Undergraduate Degree | |
| Norwegian University of Science & Technology | College/University | Doctorate Degree Graduate Degree | |
| BI Norwegian Business School | College/University | Graduate Degree Undergraduate Degree | |
Kepler Cheuvreux SA (Switzerland)
 Kepler Cheuvreux SA (Switzerland) Investment Banks/BrokersFinance Kepler Cheuvreux SA (Switzerland) (Kepler Cheuvreux Switzerland) is the Swiss broker/dealer division of Kepler Cheuvreux SA in France. The firm was founded in 1999 and is headquartered in Zurich. Kepler Cheuvreux Switzerland provides execution services platform that supports Equities, Fixed Income, Derivatives, ETFs, and Convertible Bonds. | Investment Banks/Brokers | Analyst-Equity | |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| LFF Service AB | Chief Executive Officer | ||
| Boehringer Ingelheim Norway KS | Chief Tech/Sci/R&D Officer | ||
| Fundação Luso-Brasileira para o Desenvolimento do Mundo | Director/Board Member Director/Board Member | ||
| CIRCIO HOLDING ASA | Biotechnology | Chairman Founder | |
| IDOGEN AB (PUBL) | Biotechnology | Sales & Marketing Chairman Director/Board Member | |
Cercare Medical A/S
 Cercare Medical A/S Packaged SoftwareTechnology Services Cercare Medical ApS provides automated identification of viable tissue in acute stroke. It develops technology within medical image processing and image database analytics. The firm creates diagnostic software. The company was founded by Kim Mouridsen and Mikkel Bo Hansen in October 2013 and is headquartered in Aarhus, Denmark. | Packaged Software | Corporate Officer/Principal | |
| CORLINE BIOMEDICAL AB | Medical Specialties | Director/Board Member Director/Board Member | |
Canica Holding AG
 Canica Holding AG Investment ManagersFinance Canica Holding AG is a privately owned Swiss investment company that focuses on active, long-term ownership in sectors covering branded consumer goods and services, financial investments, real estate, and retail. The company is based in Pfäffikon, Switzerland, and was founded in 2015. The company has core expertise in business development, retail, brand development, and finance. Canica creates value for its stakeholders through excellence and is passionate about its investments, employees, sustainability, and the community at large. Christer Kjos has been the CEO of the company since 2015. | Investment Managers | Director of Investments | |
| Bristol-Myers Squibb Norway Ltd. | Chief Tech/Sci/R&D Officer | ||
Gedea Biotech AB
 Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Gedea Biotech AB provides drugs for the treatment of bacterial and fungal diseases. It develops an antibiotic-free treatment for vaginal fungal infections. The company was founded by Olov Arvid Sterner, Ingrid Helena Strevens, Ulf Christian Ellervik, and Sophie Margareta Manner and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Cytovation AS
 Cytovation AS Miscellaneous Commercial ServicesCommercial Services Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn. | Miscellaneous Commercial Services | Director/Board Member | |
| EXACT THERAPEUTICS | Biotechnology | Director/Board Member | |
Stiernvalvet Invest AB
 Stiernvalvet Invest AB Investment Banks/BrokersFinance Stiernvalvet Invest AB is a Swedish company that manages and trades securities. The private company is based in Gothenburg, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Sista Versen 23245 AB
 Sista Versen 23245 AB Real Estate DevelopmentFinance Sista Versen 23245 AB provides real estate services. | Real Estate Development | Chief Executive Officer | |
Sista Versen 23068 AB
 Sista Versen 23068 AB Real Estate DevelopmentFinance Sista Versen 23068 AB provides real estate services. The private company is based in Lund, Sweden. | Real Estate Development | Chief Executive Officer | |
The Johns Hopkins University (Investment Management)
 The Johns Hopkins University (Investment Management) Investment ManagersFinance The Johns Hopkins University (Investment Management) (JHU-IM) is the pension fund management arm of The Johns Hopkins University, a private research university headquartered in Baltimore, Maryland. JHU-IM invests the endowments for the university, Johns Hopkins Hospital, and other related endowed entities. | Investment Managers | Director of Investments | |
| VITMED AS | Chief Executive Officer | ||
| ECTIN RESEARCH AB | Biotechnology | Chief Tech/Sci/R&D Officer Chairman | |
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | Biotechnology | Chairman Director/Board Member Chairman | |
Secureappbox AB
 Secureappbox AB Packaged SoftwareTechnology Services Secureappbox AB develops a communication platform for secure cloud services. The private company is based in Stockholm, Sweden. | Packaged Software | Chairman | |
| ELICERA THERAPEUTICS AB | Biotechnology | Chief Executive Officer Chairman Director/Board Member | |
| Norwegian Radium Hospital | Corporate Officer/Principal | ||
| Centre For Advanced Medical Products | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 21 |
| Norvegia | 17 |
| Portogallo | 5 |
| Svizzera | 4 |
| Stati Uniti | 3 |
Settori
| Health Technology | 15 |
| Finance | 13 |
| Consumer Services | 10 |
| Commercial Services | 4 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 250 |
| Corporate Officer/Principal | 107 |
| Chairman | 69 |
| Chief Executive Officer | 51 |
| Independent Dir/Board Member | 35 |
Contatti più connessi
- Borsa valori
- Insiders
- Carlos de Sousa
- Connessioni Società
